Single-dose pharmacokinetics and pharmacodynamics of sergliflozinetabonate, a novel inhibitor of glucose reabsorption, in healthy volunteers and patients with type 2 diabetes mellitus - Hussey, E K; Clark, R V; Amin, D M (J Clin Pharmacol, 2010)
et al.